Literature DB >> 15492016

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.

Paul Jurasz1, David Alonso-Escolano, Marek W Radomski.   

Abstract

During haematogenous metastasis, cancer cells migrate to the vasculature and interact with platelets resulting in tumour cell-induced platelet aggregation (TCIPA). We review: 1. The biological and clinical significance of TCIPA; 2. Molecular mechanisms involved in platelet aggregation by cancer cells; 3. Strategies for pharmacological regulation of these interactions. We conclude that pharmacological regulation of platelet-cancer cell interactions may reduce the impact of TCIPA on cancer biology.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15492016      PMCID： PMC1575943          DOI： 10.1038/sj.bjp.0706013

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  139 in total

1.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Pulmonary microembolism.

Authors:  A B Malik
Journal:  Physiol Rev       Date:  1983-07       Impact factor: 37.312

Review 3.  Role of plasma, platelets, and endothelial cells in tumor metastasis.

Authors:  G J Gasic
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 4.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

5.  Effects of antiplatelet agents on pulmonary metastases.

Authors:  H Bando; T Yamashita; E Tsubura
Journal:  Gan       Date:  1984-03

6.  Effects of prostacyclin on tumor cell-induced platelet aggregation.

Authors:  D G Menter; J M Onoda; J D Taylor; K V Honn
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer.

Authors:  A Lipton; S Scialla; H Harvey; R Dixon; R Gordon; R Hamilton; H Ramsey; M Weltz; R Heckard; D White
Journal:  J Med       Date:  1982

8.  Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy.

Authors:  S Casey O'Keefe; Fray F Marshall; Muta M Issa; Mary P Harmon; John A Petros
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

9.  Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

Authors:  A Falanga; S G Gordon
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

Review 10.  Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.

Authors:  Douglas E Sutherland; Ilene C Weitz; Howard A Liebman
Journal:  Am J Hematol       Date:  2003-01       Impact factor: 10.047
View more
  95 in total

1.  Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.

Authors:  Hua Liang; Chengxiang Yang; Bin Zhang; Hanbing Wang; Hongzhen Liu; Zhenlong Zhao; Zhiming Zhang; Xianjie Wen; Xiaohong Lai
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

2.  Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.

Authors:  D Bazou; M J Santos-Martinez; C Medina; M W Radomski
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Platelet activation in the postoperative period after lung transplantation.

Authors:  David I Sternberg; Daichi Shimbo; Steven M Kawut; Joydeep Sarkar; Georg Hurlitz; Frank D'Ovidio; David J Lederer; Jessie S Wilt; Selim M Arcasoy; David J Pinsky; Jeanine M D'Armiento; Joshua R Sonett
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03       Impact factor: 5.209

4.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

5.  Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.

Authors:  Radu Minea; Corey Helchowski; Barbara Rubino; Kyle Brodmann; Stephen Swenson; Francis Markland
Journal:  Toxicon       Date:  2011-02-24       Impact factor: 3.033

6.  Noninvasive label-free detection of circulating white and red blood clots in deep vessels with a focused photoacoustic probe.

Authors:  Mazen A Juratli; Yulian A Menyaev; Mustafa Sarimollaoglu; Alexander V Melerzanov; Dmitry A Nedosekin; William C Culp; James Y Suen; Ekaterina I Galanzha; Vladimir P Zharov
Journal:  Biomed Opt Express       Date:  2018-10-23       Impact factor: 3.732

7.  Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.

Authors:  Alexander Zaslavsky; Kwan-Hyuck Baek; Ryan C Lynch; Sarah Short; Jenny Grillo; Judah Folkman; Joseph E Italiano; Sandra Ryeom
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

8.  Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer.

Authors:  Rui Wang; Rebecca L Stone; Jason T Kaelber; Ryan H Rochat; Alpa M Nick; K Vinod Vijayan; Vahid Afshar-Kharghan; Michael F Schmid; Jing-Fei Dong; Anil K Sood; Wah Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

9.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

10.  Thrombospondin 1 expression and angiogenesis in breast carcinoma and their relation with platelet activity.

Authors:  Cigdem Tokyol; Gulriz Ersoz; Fatma Husniye Dilek; Ercan Gencer; Mehmet Nuri Kosar; Osman Nuri Dilek
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.